Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.
about
Sarcopenia and age-related endocrine functionThe effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repairMitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsGrowth hormone in the aging maleSarcopenia in heart failure: mechanisms and therapeutic strategiesMelatonin as a Potential Agent in the Treatment of SarcopeniaDefining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcriptionBiological effects of growth hormone on carbohydrate and lipid metabolism.Sarcopenia: etiology, clinical consequences, intervention, and assessment.Myoferlin is required for insulin-like growth factor response and muscle growth.Sarcopenia: Neurological Point of View.Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropesA multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: the HALCyon programme.Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine.The somatotropic axis and aging: mechanisms and persistent questions about practical implications.Changes in growth-related kinases in head, neck and limb muscles with age.Relationship of anabolic and catabolic biomarkers with muscle strength and physical performance in older adults: a population-based cross-sectional studySarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women.Sarcopenic obesity and endocrinal adaptation with ageThe therapeutic potential of IGF-I in skeletal muscle repair.Growth hormone responses to acute resistance exercise with vascular restriction in young and old menSarcopenia and functional decline: pathophysiology, prevention and therapy.Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithmThe frailty syndrome: a comprehensive review.Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.Modulation of the apoptotic pathway in skeletal muscle models: the role of growth hormone.Integrative Analyses of miRNA-mRNA Interactions Reveal let-7b, miR-128 and MAPK Pathway Involvement in Muscle Mass Loss in Sex-Linked Dwarf Chickens.Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.Training-related improvements in musculoskeletal health and balance: a 13-week pilot study of female cancer survivors.Royal jelly prevents the progression of sarcopenia in aged mice in vivo and in vitro.High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.Does insulin-like growth factor 1 genotype influence muscle power response to strength training in older men and women?Sarcopenia: assessment of disease burden and strategies to improve outcomes.Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older men
P2860
Q21296731-1E1FD57A-F010-4F7F-9800-86E94AB64330Q27008819-3D4FF12F-6CCA-42DD-AA3D-2B714B70EF21Q27022354-DF77914C-2DE4-4F76-A444-AA2F3037ACABQ27024785-C6FF3334-642F-4670-AC43-884A7D7B0227Q28066237-6CF12F97-FFA0-442C-AAFA-561FC4C3038AQ28076649-3DDC6F36-64A3-4D05-BA03-F5D365BE090CQ28575906-31848EA7-441B-473F-80DF-9AE9597AF85FQ33625416-56B494AE-31DF-4AE6-9C9E-BFEC93D8D28EQ33706637-4A794A91-59CC-4FE0-A8BB-684FD5B74A48Q33752882-F070D869-41F0-4072-B030-4156735DFD46Q33804857-C0CAD68B-EE5B-455D-8B1C-D6C47C44C7CFQ33808533-F4CF2748-119C-4D40-80CC-5A5479581199Q34130759-213F75A3-858A-47F1-A501-5BFA4102B8DAQ34340857-B929DB4C-4795-42D1-A6E8-B7FF973D294EQ34392400-80EA4769-8AAC-497B-BB65-EFAC6860FE09Q34708711-736EC3A2-536F-4E23-9455-72B01A1FA6A3Q35749690-06011853-7FBE-4910-8AF5-8B130421B85BQ36028202-A343687A-1C4C-4CB3-AC93-256EA358E196Q36253139-99338F55-E993-4342-9BD2-B718760AF51AQ36804785-433BFE72-2F1A-455A-8EAC-2109400E6FFBQ37068201-998CBFD0-9BBA-4D12-A617-9C800B8B9CE9Q37561781-D958FFC0-86E2-4666-B541-A3C44F590361Q37610099-084D71AD-B5F6-4752-8030-A92D483A5B92Q37670867-DFCF2A65-2DE4-4D43-A126-408B59875DCDQ37958026-338F20A1-DA24-4991-99E9-2947B7E15D19Q38723591-035702B9-ADC0-42E9-836A-88703390C253Q39609364-BC28155F-38E1-42BE-84D8-7EECD118966EQ39668813-9C4B703E-4F0F-4984-AF41-E596B2D545E9Q42576112-8D8C6C34-E0E2-4413-901B-7A012A2DB9DDQ50941487-9D54EE8C-C836-4ABA-AB44-90ED861BC2DFQ51009131-39196587-1E5B-47A4-B1DB-9DA442E6DC90Q51189557-916660B4-0CE3-4C4C-8D71-0E601EB2D77DQ53420700-89C69BB4-2F3B-41F7-92E4-AF6B9EF3B979Q55022891-FD912610-D4B6-41CD-8553-1DCC1B26A198Q57313023-5AD28A10-F368-486A-B2C7-070511EE470B
P2860
Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@en
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@nl
type
label
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@en
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@nl
prefLabel
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@en
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@nl
P2093
P2860
P1476
Modulation of GH/IGF-1 axis: p ...... ct sarcopenia in older adults.
@en
P2093
Christiaan Leeuwenburgh
Silvia Giovannini
Stephen E Borst
P2860
P304
P356
10.1016/J.MAD.2008.08.001
P577
2008-08-13T00:00:00Z